NLRP3 and COVID-19: Release of pleiotropic cytokines of the IL-1 and IL-18 family is widely thought to be due to direct or indirect activation of the NLRP3 inflammasome by SARS-CoV-2 (9, 10), but these cytokines are not always increased in COVID-19 patients (11).